ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 58 filers reported holding ADC THERAPEUTICS SA in Q4 2021. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $542,280 | +819.3% | 120,775 | +340.2% | 0.00% | – |
| Q2 2023 | $58,990 | +20.8% | 27,437 | +9.5% | 0.00% | – |
| Q1 2023 | $48,840 | -52.2% | 25,046 | -6.0% | 0.00% | -100.0% |
| Q4 2022 | $102,282 | +82.6% | 26,636 | +131.2% | 0.00% | – |
| Q3 2022 | $56,000 | -77.7% | 11,519 | +24.4% | 0.00% | -100.0% |
| Q3 2021 | $251,000 | -36.6% | 9,256 | -43.0% | 0.00% | -25.0% |
| Q2 2021 | $396,000 | – | 16,252 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 11,167,800 | $24,010,770 | 3.60% |
| Sio Capital Management, LLC | 4,020,705 | $8,644,516 | 2.20% |
| Redmile Group, LLC | 14,049,935 | $30,207,360 | 1.16% |
| Vantage Consulting Group Inc | 885,520 | $1,903,868 | 1.10% |
| Blue Owl Capital Holdings LP | 733,568 | $1,577,171 | 0.97% |
| AlphaCentric Advisors LLC | 778,000 | $1,672,700 | 0.93% |
| Affinity Asset Advisors, LLC | 600,000 | $1,290,000 | 0.45% |
| GCM Grosvenor Holdings, LLC | 410,888 | $883,409 | 0.38% |
| Indie Asset Partners, LLC | 93,839 | $201,754 | 0.22% |
| Frazier Life Sciences Management, L.P. | 1,647,030 | $3,541,115 | 0.21% |